Literature DB >> 20111984

Magnetic resonance venography and genetics of a female patient with pelvic venous thrombosis.

Thomas G Perkins1, Rahul K Mishra, Yasmin Siddiqui, Eric H Hanson, Robb K Rowley, Erica R Ramos, William W Orrison.   

Abstract

A femoral vein thrombosis, originally diagnosed with conventional ultrasound, was fully elucidated and monitored utilizing serial high-resolution magnetic resonance venography in a 19-year-old female with a family history of venous thromboembolism. Genetic testing revealed she was heterozygous for a F5 gene mutation, an abnormality that predisposes carriers to factor V Leiden thrombophilia. An additional risk factor included use of oral contraceptive pills. Subsequent testing of her family uncovered other carriers of the mutation, allowing for the implementation of preventive measures for the entire family. Although magnetic resonance venography has not yet proven to be a cost-effective method for monitoring clot resolution, the case presented here encourages further research on the clinical utility and cost-benefit of utilizing this technology for monitoring venous thrombosis and for clinical management purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111984     DOI: 10.1007/s11239-010-0443-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  31 in total

Review 1.  Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.

Authors:  S Goodacre; F Sampson; M Stevenson; A Wailoo; A Sutton; S Thomas; T Locker; A Ryan
Journal:  Health Technol Assess       Date:  2006-05       Impact factor: 4.014

2.  Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg.

Authors:  M V Huisman; F A Klok; R Karami Djurabi; D Tormene; P Simioni; P Prandoni
Journal:  J Thromb Haemost       Date:  2007-12-25       Impact factor: 5.824

3.  Sequential 2D inflow venography: initial clinical observations.

Authors:  P Lanzer; G M Gross; F S Keller; G M Pohost
Journal:  Magn Reson Med       Date:  1991-06       Impact factor: 4.668

4.  Three-dimensional low dose gadolinium-enhanced peripheral MR venography.

Authors:  W Li; V David; R Kaplan; R R Edelman
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

5.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

Review 6.  Thrombophilia and women's health: An overview.

Authors:  Isaac Blickstein
Journal:  Obstet Gynecol Clin North Am       Date:  2006-09       Impact factor: 2.844

Review 7.  Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism. American College of Chest Physicians.

Authors: 
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

8.  Experience in 207 combined MRI examinations for acute pulmonary embolism and deep vein thrombosis.

Authors:  Alexander Kluge; Clemens Mueller; Johannes Strunk; Uwe Lange; Georg Bachmann
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

Review 9.  Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Authors:  J P Vandenbroucke; F J van der Meer; F M Helmerhorst; F R Rosendaal
Journal:  BMJ       Date:  1996-11-02

10.  Magnetic resonance direct thrombus imaging of the evolution of acute deep vein thrombosis of the leg.

Authors:  R E Westerbeek; C J Van Rooden; M Tan; A P G Van Gils; S Kok; M J De Bats; A De Roos; M V Huisman
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.